Recombinant Human VEGFR2/KDR His-tag Protein, CF Summary
Details of Functionality |
Measured by its ability to inhibit the VEGF-dependent proliferation of HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci. USA 87:1323. The ED50 for this effect is 0.350-3.50 μg/mL. |
Source |
Chinese Hamster Ovary cell line, CHO-derived human VEGFR2/KDR/Flk-1 protein Ala20-Glu764, with a C-terminal 6-His tag |
Accession # |
|
N-terminal Sequence |
Ala20 |
Protein/Peptide Type |
Recombinant Proteins |
Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. |
Endotoxin Note |
<0.10 EU per 1 μg of the protein by the LAL method. |
Applications/Dilutions
Dilutions |
|
Theoretical MW |
84 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
SDS-PAGE |
114-126 kDa |
Packaging, Storage & Formulations
Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 3 months, -20 to -70 °C under sterile conditions after reconstitution.
|
Buffer |
Lyophilized from a 0.2 μm filtered solution in PBS. |
Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. |
Reconstitution Instructions |
Reconstitute at 1.00 mg/mL in PBS. |
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human VEGFR2/KDR His-tag Protein, CF
Background
Vascular
endothelial Growth Factor Receptor 2 (VEGFR2), also known as FLK-1, KDR, and
CD309, is a type I single-pass membrane receptor. Mature VEGFR2 contains a 745 amino acid
extracelluar domain with seven immunoglobulin-like repeats, 21 transmembrane
domain and 571 cytoplasmic domain. Within the extracellular domain, human
VEGFR2 shares 80% homology with that of mouse and rat. VEGFR2, VEGFR1(Flt-1)
and VEGFR3(Flt-4) belong to the class III subfamily of receptor tyrosine
kinases (RTKs). All three receptors have almost exclusive expression in the
endothelial cells and play essential roles in vasculogenesis and angiogenesis.
VEGFR2 is the receptor for VEGF-A, VEGF-C, VEGF-D, and VEGF-E (viral homologs)
(1, 2). Monomeric VEGFR2 dimerizes after
binding to dimeric ligand and phosphorylate the Tyr in the cytoplasmic domain
(3). VEGFR2 can also form heterodimer
with VEGFR1 and VEGFR3 (4-6). Alternative
splicing isoforms 2 and 3 which lack the transmembrane and cytoplasmic domains function
as decoy receptors (7, 8). Targeting the signaling pathways of VEGFR1 and VEGFR2
are potential therapeutic targets for the treatment of inflammation and multiple
tumors including breast, gastric, and lung carcinomas (9-12). Cancer
immunotherapies using VEGF and VEGFR2 monoclonal antibodies may also be
effective in combination with programmed cell death protein 1 (PD-1)/
programmed cell death ligand 1 (PD-L1) immune checkpoint blockade (13).
- Ferra, N. and Davis-Smyth, T. (1997) Endocr. Rev. 18:4.
- Wise, L.M. et al. (2012) Cell Microbiol. 13:1376.
- Lepanen, V.M. et al. (2010) Proc. Natl. Acad. Sci. USA 107:2425.
- Cai, M. et al. (2017) Vascul. Pharmacol. 88:11.
- Nilsson, I. et al. (2010) EMBO J. 29:1377.
- Dixelius, J. et al. (2003) J. Biol. Chem. 278:40973.
- Albuquerque, R.J. et al. (2009) Nat. Med. 15:1023.
- Jin, P. et al. (2008) Arthritis Res. Ther. 10:R73.
- Shibuya, M. (2015) Endocr Metab Immune Disord Drug Targets. 15:135.
- Farzaneh Behelgardi, M. et al. (2020), Mol Biol Rep. 47:2061.
- Lian, L. et al. (2019) BMC Cancer. 19:183.
- Hu, C. et al. (2019) Onco. Targets Ther. 12:933.
- Gao, F. et al. (2020) Curr. Cancer Drug Targets. 20:3.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: ELISA
Species: Hu
Applications: Block, CyTOF-ready, Flow, IHC, WB
Species: Hu
Applications: CyTOF-ready, Dual ISH-IHC, ELISA(Cap), ELISA(Det), ELISA(Sta), Flow, ICC, IHC, IP, Simple Western, WB
Species: Rt
Applications: IHC, WB
Species: Mu
Applications: CyTOF-ready, Flow, WB
Species: Hu, Mu, Rt
Applications: CyTOF-ready, Flow, ICC, IHC, Simple Western, WB
Species: Hu, Mu, Rt
Applications: CyTOF-ready, IHC, ICFlow, Simple Western, WB
Species: Hu
Applications: ChIP, ELISA, ICC/IF, WB
Species: Hu, Mu
Applications: CyTOF-ready, Dual ISH-IHC, Flow, IHC, Simple Western, WB
Species: Hu
Applications: ELISA
Species: Mu, Rt
Applications: Block, CyTOF-ready, Flow, IHC, WB
Species: Hu, Pm, Mu, Rt
Applications: ELISA, Flow, ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: ELISA
Species: Hu
Applications: BA
Species: Mu
Applications: Dual ISH-IHC, IHC, WB
Species: Hu
Applications: Bioactivity
Publications for VEGFR2/KDR/Flk-1 (10964-KD) (0)
There are no publications for VEGFR2/KDR/Flk-1 (10964-KD).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for VEGFR2/KDR/Flk-1 (10964-KD) (0)
There are no reviews for VEGFR2/KDR/Flk-1 (10964-KD).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for VEGFR2/KDR/Flk-1 (10964-KD) (0)
Additional VEGFR2/KDR/Flk-1 Products
Blogs on VEGFR2/KDR/Flk-1